Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Autor: Gottlieb, Robert L, Vaca, Carlos E, Paredes, Roger, Mera, Jorge, Webb, Brandon J, Perez, Gilberto, Oguchi, Godson, Ryan, Pablo, Nielsen, Bibi U, Brown, Michael, Hidalgo, Ausberto, Sachdeva, Yessica, Mittal, Shilpi, Osiyemi, Olayemi, Skarbinski, Jacek, Juneja, Kavita, Hyland, Robert H, Osinusi, Anu, Chen, Shuguang, Camus, Gregory, Abdelghany, Mazin, Davies, Santosh, Behenna-Renton, Nicole, Duff, Frank, Marty, Francisco M, Katz, Morgan J, Ginde, Adit A, Brown, Samuel M, Schiffer, Joshua T, Hill, Joshua A, Nielsen, Henrik

Publikováno v: Gottlieb, R L, Vaca, C E, Paredes, R, Mera, J, Webb, B J, Perez, G, Oguchi, G, Ryan, P, Nielsen, B U, Brown, M, Hidalgo, A, Sachdeva, Y, Mittal, S, Osiyemi, O, Skarbinski, J, Juneja, K, Hyland, R H, Osinusi, A, Chen, S, Camus, G, Abdelghany, M, Davies, S, Behenna-Renton, N, Duff, F, Marty, F M, Katz, M J, Ginde, A A, Brown, S M, Schiffer, J T, Hill, J A, GS-US-540-9012 (PINETREE) Investigators & Nielsen, H 2022, ' Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients ', The New England Journal of Medicine, vol. 386, no. 4, pp. 305-315 . https://doi.org/10.1056/NEJMoa2116846
The New England Journal of Medicine
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with Covid-19 who are at high risk for disea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9317030589eded6198a6dff29ba59a1
https://vbn.aau.dk/da/publications/65f84a60-59b0-4784-af13-20bb7af16518

LB1. Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

Autor: Hill, Joshua A, Paredes, Roger, Vaca, Carlos, Mera, Jorge, Webb, Brandon J, Perez, Gilberto, Oguchi, Godson, Ryan, Pablo, Gerstoft, Jan, Brown, Michael, Schiffer, Joshua, Brown, Samuel, Katz, Morgan, Ginde, Adit A, Camus, Gregory, Porter, Danielle P, Hyland, Robert H, Chen, Shuguang, Juneja, Kavita, Osinusi, Anu, Duff, Frank, Gottlieb, Robert L

Publikováno v: Open Forum Infectious Diseases

Background Remdesivir (RDV) is a potent nucleotide prodrug inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase that has demonstrated efficacy in the treatment of patients hospitalized with moderate to severe COVID-19. This Phase 3 (GS-US-540–9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57124aba4340510cfbabe4d1183cee90
https://doi.org/10.1093/ofid/ofab466.1642

Surgical President's Concern

Autor: Smith, Rodney, Ross, James, Duff, Frank, Kay, Andrew Watt

Publikováno v: The British Medical Journal, 1974 Apr . 2(5911), 183-183.

Externí odkaz: https://www.jstor.org/stable/20468806

Understanding the Mystical Body

Autor: Duff, Frank

Publikováno v: The Furrow, 1957 Jul 01. 8(7), 444-451.

Externí odkaz: https://www.jstor.org/stable/27657204

The Living Core

Autor: Duff, Frank

Publikováno v: The Furrow, 1956 Jun 01. 7(6), 339-344.

Externí odkaz: https://www.jstor.org/stable/27656938